The knowledge and considerations of the physicians regarding the inhaler devices in asthma and COPD: The INTEDA-1 study;Asti{dotless}m ve koah tedavisinde kullani{dotless}lan inhaler cihazlar hakki{dotless}nda hekimlerin bilgi düzeyleri ve görüşleri: INTEDA-1 Çali{dotless}şmasi{dotless}

Tuberkuloz ve Toraks

Volumn 61, Issue 3, 2013, Pages 183-192

  Çalişkaner, A Zafer ^a   Öztürk, Can ^b   Ceylan, Emel ^c   Pekcan, Sevgi ^a   Yilmaz, Özge ^d   Öztürk, Sami ^e   Can, Cenk ^f   Şener, Osman ^g   Yilmaz Turay, Ülkü ^h   Koç, Nihal ⁱ   Ersoy, Ramazan ^j  

^a NECMETTIN ERBAKAN UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c ADNAN MENDERES UNIVERSITY   (Turkey)

^d CELAL BAYAR UNIVERSITY   (Turkey)

^e GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^f EGE UNIVERSITY   (Turkey)

^g GULHANE SCHOOL OF MEDICINE   (Turkey)

^h Ataturk Chest Disease and Thoracic Surgery Education and Research Hospital Ankara   (Turkey)

ⁱ ISTANBUL UNIVERSITY   (Turkey)

^j Yedikule Chest Diseases and Chest Surgery Training and Research Hospital   (Turkey)

more..

Author keywords

Asthma; COPD; Device education; Inhalation devices; Physician's knowledge

Indexed keywords

ADULT; ARTICLE; ASTHMA; ATTITUDE TO HEALTH; AWARENESS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INHALER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICIAN; PROSPECTIVE STUDY; QUESTIONNAIRE; AGED; CLINICAL TRIAL; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; MULTICENTER STUDY; NEBULIZER; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TURKEY;

BRONCHODILATING AGENT;

ADMINISTRATION, INHALATION; ADULT; AGED; ASTHMA; AWARENESS; BRONCHODILATOR AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PHYSICIANS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TURKEY;

EID: 84888808493     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: 10.5578/tt.5343     Document Type: Article

References (23)

1. Global Initiative for Asthma, guidelines www.ginasth-ma.com/
2. Chronic obstructive pulmonary disease, guidelines. www.goldcopd.com/Guidelineitem.asp
3. Everard ML. Regimen and device compliance: key factors in determining therapeutic outcomes. J Aerosol Med 2006; 19: 67-73.
4. Berger W. Aerosol devices and asthma therapy. Curr Drug De-liv 2009; 6: 38-49.
5. Giraud V, Roche N. Misuse of corticosteroid metered-dose inhaler is associated with decreased asthma stability. Eur Res-pir J 2002; 19: 246-51.
6. Campos HS, Lemos ACM. Asthma and COPD according to the pulmonologist. J Bras Pneumol 2009; 35: 301-9.
7. Dolovich M. Drug delivery systems for administration of inhaled therapy in patients with chronic obstructive pulmonary disease. American Health and Drug Benefits 2008; 1(Suppl 4): 12.
8. Plaza V, Sanchis J, Roura P, Molina J, Calle M, Quirce S, et al. Physicians' knowledge of inhaler devices and inhalation techniques remains poor in Spain. J Aerosol Med Pulm Drug Deliv 2012; 25: 16-22. doi: 10.1089/jamp.2011.0895.
9. Hanania NA, Wittman R, Kesten S, Chapman KR. Medical personnel's knowledge of and ability to use inhaling devices. Me-tered-dose inhalers, spacing chambers, and breath-actuated dry powder inhalers. Chest 1994; 105: 111-6.
10. Anderson PJ. History of aerosol therapy: liquid nebulisation to MDIs to DPIs. Respir Care 2005; 50: 1139-50.
11. Melani AS. Inhalatory therapy training: a priority challenge for the physician. ACTA BIOMED 2007; 78: 233-45.
12. Molimard M, Raherison C, Lignot S, Depont F, Abouelfath A, Moore N. Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care. J Aerosol Med 2003; 16: 249-54.
13. Melani AS, Bonavia M, Cilenti V, Cinti C, Lodi M, Martucci P, et al; Gruppo Educazionale Associazione Italiana Pneumologi Ospedalieri. Inhaler mishandling remains common in real life and is associated with reduced disease control. Respir Med 2011; 105: 930-8. doi: 10.1016/j.rmed.2011.01.005.
14. Erickson SR, Landino HM, Zarowitz BJ, Kirking DM. Pharmacists' understanding of patient education on metered-dose inhaler technique. Ann Pharmacother 2000; 34: 1249-56.
15. Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pulmonary disease and asthma. Expert Rev Respir 2012; 6: 91-103.
16. Ceylan E, Akkoçlu A, Ergör G, Yildiz F, Itil O. Inhaler use and device preferences of asthmatic patients: role of education on appropriate device use. Turkish Respiratory Journal 2008; 10: 40-7.
17. Schulte M, Osseiran K, Betz R, Wencker M, Brand P, Meyer T, et al. Handling of and preferences for available dry powder inhaler systems by patients with asthma and COPD. J Aerosol Med Pulm Drug Deliv 2008; 21: 321-8. doi: 10.1089/jamp.2007.0634
18. Loh LC, Wong PS. Asthma prescribing practices of government and private doctors in Malaysia- A nationwide questionnaire survey. Asian Pacific Journal of Allergy and Immunology 2005; 23: 7-17.
19. Brocklebank D, Ram F, Wright J, Barry P, Cates C, Davies L, et al. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature. Health Technol Assess 2001; 5: 1-149.
20. Lenney J, Innes JA, Crompton GK. Inappropriate inhaler use: assessment of use and patient preference of seven inhalation devices. EDICI. Respir Med 2000; 94: 496-500.
21. Rönmark E, Jögi R, Lindqvist A, Haugen T, Meren M, Loit HM, et al. Correct use of three powder inhalers: comparison between Diskus, Turbuhaler, and Easyhaler. J Asthma 2005; 42: 173-8.
22. Crompton GW, Barnes PJ, Broeders M, et al. The need to improve inhalation technique in Europe: a report from the Aerosol Drug Management Improvement Team. Respir Med 2006; 100: 1479-94.
23. Fink JB, Rubin BK. Problems with inhaler use: a call for improved clinician and patient education. Respir Care 2005; 50: 1360-74.